Completed PHASE3 INTERVENTIONAL 3-arm NCT01468025

Effectiveness of Theramine on Chronic Back Pain

A Randomized Double-blind Placebo Study to Determine the Effectiveness of Theramine and a Low Dose Naproxen on the Management of Chronic Back Pain

Sponsor: Targeted Medical Pharma

Conditions Low Back Pain

Interventions Active Theramine and Active Naproxen Naproxen and Theramine-like placebo Theramine and naproxen-like placebo

Updated 6 times since 2017 Last updated: Nov 5, 2011 Started: Feb 28, 2009 Primary completion: Jul 31, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01468025, this PHASE3 trial focuses on Low Back Pain and remains completed. Sponsored by Targeted Medical Pharma, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Targeted Medical Pharma

Data source: Targeted Medical Pharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.